eMudhra IPO: The company intends to utilize the net proceeds from the fresh issue to pre-pay or repay in part or full, the existing loans availed by the company to an extent of Rs 35 crore. Rs 40.2 crore will be used for funding its working capital requirements.

Choice Equity Broking has come out with its report on eMudhra. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on May 19, 2022.

The IPO, sized at Rs 413 crore, comprises fresh shares of Rs 161 crore and an offer for sale worth Rs 252 crore by shareholders and promoters.

The company aims to mop up Rs 1,501 crore in total from a fresh issue of shares worth Rs 1,004 crore and an offer for sale of Rs 497.73 crore

Hem Securities has come out with its report on Paradeep Phosphates. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on May 17, 2022.

Hem Securities has come out with its report on Paradeep Phosphates. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on May 17, 2022.

Hem Securities has come out with its report on Paradeep Phosphates. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on May 17, 2022.

Hem Securities has come out with its report on Ethos. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on May 17, 2022.

Ethos IPO: The company plans to garner Rs 472 crore through fresh issue of equity shares aggregating to Rs 375 crore and Rs 97.29 crore through the sale of 1,108,037 shares by the shareholders and promoters

Around 50 percent of the net offer will be reserved for QIBs, 35 percent for retail investors, and the remaining 15 percent for non-institutional investors.

The company aims to mop up Rs 1,501 crore by a combination of fresh issue of equity shares aggregating upto Rs 1,004 crore and an offer for sale (OFS) of 118,507,493 equity shares of Rs 10 each aggregating up to Rs 497.73 crore.

Choice Equity Broking has come out with its report on Ethos. The research firm has recommended to #39;#39;Avoid#39;#39; the ipo in its research report as on May 14, 2022.

Choice Equity Broking has come out with its report on Ethos. The research firm has recommended to #39;#39;Avoid#39;#39; the ipo in its research report as on May 14, 2022.

ICICI Direct has come out with its report on Ethos. The research firm has recommended to #39;#39;Avoid#39;#39; the ipo in its research report as on May 17, 2022.

Choice Equity Broking has come out with its report on Paradeep Phosphates. The research firm has recommended to #39;#39;Subscribe#39;#39; the ipo in its research report as on May 16, 2022.

Welspun Corp, ITC and Hindustan Aeronautics were among the stocks that touched their 52-week high on the BSE

The Sensex has lost more than Rs 17.59 lakh crore of its market capitalisation in May alone. The mcap was Rs 266.98 lakh crore at the close on April 29 and has now collapsed to Rs 249.38 lakh crore

Among sectors, Nifty FMCG and Nifty pharma rose a percent each, while Nifty PSU bank, energy and IT indices fell 0.5-1.5 percent

Among sectors, Nifty FMCG and Nifty pharma rose a percent each, while Nifty PSU bank, energy and IT indices fell 0.5-1.5 percent

On the BSE, all sectoral indices ended in the green The metal index was up over 7 percent and other sectoral indices rallied between 1-3 percent

Voltas, HDFC Bank, REC, Lupin, Dixon Technologies and Indus Towers were among the stocks that touched their 52-week low on the BSE

For the week, the Sensex declined 2,041.96 points, or 3.72 percent, and the Nifty shed 629.05 points, or 3.83 percent

More than 300 stocks, including Wockhardt, Voltas, Sun TV Network, RBL Bank, Nestle India, Jubilant FoodWorks and IFCI, touched their 52-week low on the BSE

Over 250 stocks, including Wipro, Torrent Pharmaceuticals, Jindal Saw, Hindustan Zinc, Granules India, Aurobindo Pharma, Ashoka Buildcon, IDFC First Bank, and KEC International, touched their 52-week low on the BSE.

More than 100 stocks, including SAIL India, Rallies India, Dabur India, Nestle India and Granules India, touched their 52-week low on the BSE

More than 100 stocks, including SAIL India, Rallies India, Dabur India, Nestle India and Granules India, touched their 52-week low on the BSE

Broader indices underperformed the benchmarks, with BSE midcap and smallcap indices shedding nearly 2 percent each

More than 100 stocks, including Wipro, Zomato, Welspun India, Vivimed Labs, Spicejet PNB Housing Finance, Glenmark Pharmaceuticals, touched their 52-week low on the BSE.

US Fed’s decision to remain less hawkish with a 50 bps rate hike downplayed the investors#39; worries, helping the global markets to rally. Profit booking in the second half led the markets to pare all gains

With the US Federal Open Market Committee meeting outcome later on May 4, volatility may remain at elevated levels in the coming sessions too. Investors need to be cautious, using dips to make fresh positions in fundamentally sound stocks.

You can look at health policies with co-pay or sub-limits to keep a tight lid on premiums, but do note that such restrictions will also lead to inadequate coverage.

LIC#39;s IPO is priced at a significant discount to private peers. Why so?

The company said will use the fresh funds to drive sales growth, product development, and for strategic hiring.

The company said will use the fresh funds to drive sales growth, product development, and for strategic hiring.

The company said will use the fresh funds to drive sales growth, product development, and for strategic hiring.

Market leader LIC logged in a 51 percent surge in first-year premiums in March, while it jumped nearly 8 percent to Rs 1.98 trillion for 2021-22

Market leader LIC logged in a 51 percent surge in first-year premiums in March, while it jumped nearly 8 percent to Rs 1.98 trillion for 2021-22

The new centre is also working on technology for streaming platform ZEE5 to improve content discoverability.

The revenue from operations for the fourth quarter of FY22 grew by 16.39 percent to reach Rs 5,931.12 crore as against Rs 5,095.81 crore reported in the third quarter.

Arihant Capital is bullish on Raymond has recommended buy rating on the stock with a target price of Rs 1362 in its research report dated May 19, 2022.

YES Securities is bullish on IRB Infrastructure Developers has recommended buy rating on the stock with a target price of Rs 328 in its research report date May 18, 2022.

YES Securities is bullish on Indraprastha Gas has recommended buy rating on the stock with a target price of Rs 520 in its research report date May 18, 2022.

YES Securities is bullish on ITC has recommended buy rating on the stock with a target price of Rs 308 in its research report date May 18, 2022.

KR Choksey recommended accumulate rating on Minda Corporation with a target price of Rs 224 in its research report dated May 19, 2022.

KR Choksey is bullish on Ami Organics has recommended buy rating on the stock with a target price of Rs 1229 in its research report dated May 19, 2022.

Geojit recommended is bullish on Hindustan Unilever has recommended buy rating on the stock with a target price of Rs 2620 in its research report dated May 19, 2022.

Emkay Global Financial recommended hold rating on Star Cement with a target price of Rs 100 in its research report dated May 18, 2022.

Emkay Global Financial is bullish on Westlife Development has recommended buy rating on the stock with a target price of Rs 650 in its research report dated May 19, 2022.

Emkay Global Financial is bullish on Indraprastha Gas has recommended buy rating on the stock with a target price of Rs 450 in its research report dated May 19, 2022.

Emkay Global Financial is bullish on Bharti Airtel has recommended buy rating on the stock with a target price of Rs 850 in its research report dated May 18, 2022.

Anand Rathi is bullish on Intellect Design Arena has recommended buy rating on the stock with a target price of Rs 850 in its research report dated May 18, 2022.

Arihant Capital recommended accumulate rating on Manappuram Finance with a target price of Rs 118 in its research report dated May 19, 2022.